Autopsy report · NCT01029106
Gynecare TVT Secur for the Management of Stress Urinary Incontinence (SUI)
Cause of deathOther
“Study design required a change in device”
Life of this trial
- Registered 1 month after it had already started.
- 125 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Sunnybrook Health Sciences Centre
- Sponsor type
- University, hospital or other
- Conditions
- Stress Urinary Incontinence
- Interventions
- Gynecare TVT Secur
- Participants
- 125 (planned, not actual)
- Sites
- 1
- Countries
- Canada
Trials that died the same way
- Study to Optimize the IOL Constant of a New Multifocal Intraocular Lens
“Sponsor decided to modify the prototype device used in study” - A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo
“Study design was changed” - Effectiveness and Tolerability of LabiaStick#01 in Subjects With Symptomatic Non-hypertrophic Chronic Vulvar Dermatoses
“New study design will be made” - A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension
“Decision to change the study design” - Security and Efficacy of Dorilax® (Fixed Association of Paracetamol 350 mg, Carisoprodol 150 mg and Caffeine 50 mg) Plus Thermal Band Compared to Placebo Plus Thermal Band in the Treatment of Acute Low Back Pain.
“Study design will be reformulated”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.